✦ LIBER ✦

Bivalirudin provides increasing benefit with declining renal function in percutaneous coronary intervention: A meta-analysis of 5,035 patients enrolled in three randomized trials

✍ Scribed by Derek P. Chew; Deepak L. Bhatt; Peter B. Berger; Tim Henry; Peter A. McCullough; Frederick Feit; John A. Bittl; A. Michael Lincoff

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bivalirudin provides increasing benefit

✍ Derek P Chew; Deepak L Bhatt; William Kimball; Timothy D Henry; Peter Berger; Pe 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 103 KB

A Meta-Analysis of 17 Randomized Trials

✍ Albert Schömig; Julinda Mehilli; Antoinette de Waha; Melchior Seyfarth; Jürgen P 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 283 KB

Benefit, rather than safety, of cilostaz

✍ Hisato Takagi; Takuya Umemoto 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 409 KB

DOES TRIPLE THERAPY WITH CILOSTAZOL DECR

✍ Amita Singh; Frederick Feit; Sripal Bangalore 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Impact of baseline hemorrhagic risk on t

✍ Tarantini, Giuseppe; Brener, Sorin Jakob; Barioli, Alberto; Gratta, Andrea; Paro 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 868 KB

A Comparison of Intracoronary with Intra

✍ GANG FU; LEI JIA; XIN ZHAO; YIBO WANG; XIAOHUI CHEN; YANG YANG; NA LU; WEI ZHAO; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 793 KB